-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Pacira BioSciences, Maintains $30 Price Target

Benzinga·01/09/2026 09:51:44
Listen to the news
Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $30 price target.